Profiel
Anju Chatterji currently works at HilleVax, Inc., as Chief Technology Officer from 2023.
Dr. Chatterji also formerly worked at Grifols Biologicals, Inc., as Director-Technical Development and Catalyst Biosciences, Inc., as Senior VP-Biologics Development & Manufacturing.
Dr. Chatterji received her doctorate degree from Indian Agricultural Research Institute.
Actieve functies van Anju Chatterji
| Bedrijven | Functie | Begin |
|---|---|---|
| HILLEVAX, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
Eerdere bekende functies van Anju Chatterji
| Bedrijven | Functie | Einde |
|---|---|---|
Grifols Biologicals, Inc.
Grifols Biologicals, Inc. Pharmaceuticals: MajorHealth Technology Produces protein therapies and products for patients | Hoofd Techniek/Wetenschap/O&O | - |
| CATALYST BIOSCIENCES | Corporate Officer/Principal | - |
Opleiding van Anju Chatterji
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Indian Agricultural Research Institute
Indian Agricultural Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Grifols Biologicals, Inc.
Grifols Biologicals, Inc. Pharmaceuticals: MajorHealth Technology Produces protein therapies and products for patients | Health Technology |
Catalyst Biosciences, Inc.
Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
HilleVax, Inc.
HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
















